Michael Seckl MBBS, PhD, BSc, MRCP

Michael Seckl trained in medicine at UCL/UCLH gaining a BSc in immunology in 1983 and his MBBS in 1986. He then obtained his MRCP before entering specialist training in Medical Oncology between 1989-1995.

During this period he spent 3 years at the Imperial Cancer Research Fund (London Research Institute; LRI) working on signal transduction in model and lung cancer cells and was awarded his PhD in 1995 (University of London). He was then appointed as a Senior Lecturer at Imperial College whilst working as a post-doctoral fellow at the LRI enabling a series of successful grant applications to support his on going work in lung cancer. His clinical appointment also linked him to the national trophoblastic disease service and so a second stream of research was established.

He became a Reader and FRCP in 2000 and Professor in 2002 and currently heads up Molecular Oncology with its associated Lung Cancer Research team. He is Director of the Charing Cross/ Imperial College Trophoblastic Disease Service and supraregional tumour marker assay service. He is an international leader in trophoblastic disease, is president of the international trophoblastic disease society (ISSTD.org), on the founding council of the european organisation for the treatment of trophoblastic disease (EOTTD.com), is a visiting Professor at Peking Union Medical College and serves on several editorial boards and grants committees.